Schedule 13D ownership disclosure

APRICUS BIOSCIENCES INC

Security class unavailable · CUSIP: 03832V307

Event date: 2018-09-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-18-006352
Form type
SC 13D
Filer
SEELOS THERAPEUTICS, INC.
CIK
CIK 1017491
Filed
Sep 27, 2018
Reporting period
Sep 20, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub